Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Familial lecithin-cholesterol acyltransferase deficiency in a Japanese family: Evidence for functionally defective enzyme in homozygotes and obligate heterozygotes

  • 38 Accesses

  • 15 Citations

Summary

Lecithin-cholesterol acyltransferase (LCAT) mass and activity were measured in a Japanese family with familial LCAT deficiency. The two LCAT-deficient subjects had LCAT mass approximately 40–46% of normal (2.65 and 2.31 μg/ml respectively, as compared with normal levels of 5.76±0.95 μg/ml in 19 Japanese subjects) and enzyme activity less than 10% of normal (9.1 and 8.3 nmol/h/ml respectively, as compared with normal levels of 100 nmol/h/ml). All obligate heterozygotes examined, including the father of the two LCAT-deficient subjects, and all five children of the deficient subjects had LCAT mass approximately 72–80% of the normal LCAT mass (4.12, 4.38, 4.45, 4.48, 4.49, 4.61 μg/ml, respectively) and LCAT activity approximately half normal (51.9, 52.4, 54.2, 56.6, and 57.2 nmol/h/ml). We conclude that the two LCAT-deficient subjects of this family have functionally defective enzyme. Furthermore, the data suggest that the plasma of the obligate heterozygotes contain both normal and functionally defective enzymes.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Albers JJ, Adolphson JL, Chen C-H (1981) Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase. J Clin Invest 67:141–148

  2. 2.

    Chen C-H, Albers JJ (1982) Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J Lipid Res 23: 680–691

  3. 3.

    Albers JJ, Chen C-H, Adolphson JL (1981) Familial lecithincholesterol acyltransferase: Identification of heterozygotes with half-normal enzyme activity. Human Genetics 58:306–309

  4. 4.

    Albers JJ, Utermann G (1981) Genetic control of lecithin-cholesterol acyltransferase: measurement of LCAT mass in a large kindred with LCAT deficiency. Am J Hum Genet 33:702–708

  5. 5.

    Utermann C, Menzel HJ, Dieker D, Langer KH, Fiorelli GI (1981) Lecithin: cholesterol acyltransferase deficiency: autosomal recessive transmission in a large kindred. Clin Genet 19:448–455

  6. 6.

    Albers JJ, Gjone E, Adolphson JL, Chen C-H, Teisberg P, Torsvik P (1981) Familial lecithin-cholesterol acyltransferase (LCATase) in four Norwegian families: Evidence for low levels of a functionally defective enzyme. Acta Medica Scand 210: 455–459

  7. 7.

    Albers JJ, Wahl PW, Cabana VG, Hazzard WR, Hoover JJ (1976) Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism 25:633–644

  8. 8.

    Cheung MC, Albers JJ (1977) The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. J Clin Invest 60:43–50

  9. 9.

    Albers JJ, Cheung MC, Ewens SL, Tollefson JH (1981) Characterization and immunoassay of apolipoprotein D. Atherosclerosis 39:395–409

  10. 10.

    Albers JJ, Cabana VG, Hazzard WR (1979) Immunoassay of human plasma apolipoprotein B. Metabolism 25:1339–1351

  11. 11.

    Warnick GR, Albers JJ (1978) A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19:65–76

  12. 12.

    Albers JJ, Bergelin RO, Adolphson JL, Wahl PW (1982) Population-based reference values for lecithin-cholesterol acyltransferase (LCAT). Atherosclerosis 43:369–379

Download references

Author information

Correspondence to John J. Albers.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Albers, J.J., Chen, C., Adolphson, J. et al. Familial lecithin-cholesterol acyltransferase deficiency in a Japanese family: Evidence for functionally defective enzyme in homozygotes and obligate heterozygotes. Hum Genet 62, 82–85 (1982). https://doi.org/10.1007/BF00295608

Download citation

Keywords

  • Enzyme Activity
  • Internal Medicine
  • Normal Level
  • Metabolic Disease
  • Japanese Subject